Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-17

FDA Approved: TRIKAFTA — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approved a supplemental application for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor) from Vertex Pharmaceuticals Incorporated. The approval covers changes un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

SUPPL AP for TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)